GQ India examines the online hype around peptides for muscle, recovery and leanness. Only the opening line is available.
Recap by typeshit. Post by @gqindia on Instagram.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
29:53
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
The Tommy Thompson-chaired company says the dissolving needles could skip injections for sports medicine peptides. It remains investigational and is not FDA approved.
The market research firm credits GLP-1 demand for a projected 9.5% yearly growth rate, with Asia Pacific expected to grow fastest.
Loading…